Diamond Shruumz Recall Issued Following FDA Warning on Health Risks

Nearly 40 illnesses have been linked to recalled Shruumz mushroom products, which may cause cause seizures, abnormal heart rates, nausea and vomiting.

Following a warning issued last month by federal health officials about dozens of reports involving severe illnesses linked to Diamond Shruumz, the manufacturer has announced a recall that impacts all flavors of the chocolate bars, cones and gummies, which may contain dangerous amounts of muscimol, a chemical that can cause severe symptoms and injuries.

Diamond Shruumz are a mushroom micro dosing brand, which are marketed as dietary supplement that provides users a “sumptious experience and a more creative state of mind.” However, the products reportedly have no psilocybin in them, meaning the chocolates contain no actual psychedelics or scheduled drugs.

The U.S. Food and Drug Administration (FDA) announced the Diamond Shruumz recall on June 28, after discovering that the products’ Certificates of Analysis (COAs) showed higher than normal amounts of muscimol, a compound found in Amanita mushrooms, which might be responsible for symptoms similar to those experienced by individuals who fell ill after consuming Diamond Shruumz products.

Did You Know?

AT&T Data Breach Impacts Millions of Customers

More than 73 million customers of AT&T may have had their names, addresses, phone numbers, Social Security numbers and other information released on the dark web due to a massive AT&T data breach. Lawsuits are being pursued to obtain financial compensation.

Learn More

The recall comes after the FDA issued a Diamond Shruumz warning on June 11, following reports of illnesses. Then, on June 18, 2024, the FDA and CDC, along with America’s Poison Centers and state and local partners, announced an investigation into illnesses linked to Diamond Shruumz-brand Chocolate Bars, Cones, and Gummies. Samples of these products were collected and analyzed as part of the investigation.

In total, at least 39 consumer illnesses have been linked to the mushroom products in 20 different states, including 23 reports of individuals being hospitalized. These consumers reported experiencing seizures, agitation, involuntary muscle contractions, loss of consciousness, confusion, sleepiness, nausea and vomiting, abnormal heart rates, and hyper/hypotension.

The FDA notice indicates that retailers and wholesalers should stop selling the products, quarantine any inventory immediately, and contact their sales representative to begin the return and refund process. Upon contacting their sales representatives, the manufacturer, Prophet Premium Blends will provide return shipping labels, verify the inventory, and then issue the refund.

The recall includes Diamond Shruumz infused cones, chocolate bars, and gummies. A full list of affected items, their UPC codes, and product images are available in the FDA’s recall notice.

States that have been impacted by this recall include Alabama, Arizona, California, Colorado, Georgia, Indiana, Iowa, Kentucky, Maryland, Minnesota, Missouri, Montana, Nevada, New Jersey, New York, North Carolina, Ohio, Pennsylvania, South Carolina, Tennessee.

Consumers who have bought Diamond Shruumz products are advised to discontinue use, dispose of the product, and contact Prophet Premium Blends either by phone at (209) 314-0881 or via email at info@diamondshruumz.com. They should provide their order number to initiate the refund process and inform Prophet Premium Blends that the product has been discarded to prevent further access.

If an individual becomes ill after consuming these products they should contact their healthcare provider and/or call the Poison Help Line at 1-800-222-1222, informing them that you recently consumed Diamond Shruumz-brand Chocolate Bars, Cones, or Gummies. Healthcare providers should report such illnesses to their local health department and/or the Poison Help Line.


Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Uber Driver Sexual Assaults and Misconduct Reports Must Be Disclosed in Lawsuit Discovery
Uber Driver Sexual Assaults and Misconduct Reports Must Be Disclosed in Lawsuit Discovery (Posted today)

A federal magistrate judge is forcing Uber to hand over potentially hundreds of thousands of incident files involving reports of passengers who suffered sexual misconduct or sexual assault at the hands of the rideshare service's drivers.

Abbott May Remove Infant Formula for Preemies Off the Market Due to Similac NEC Lawsuits
Abbott May Remove Infant Formula for Preemies Off the Market Due to Similac NEC Lawsuits (Posted yesterday)

Abbott Laboratories is considering removing Similac infant formula products designed for preterm babies from the market, as it faces hundreds of lawsuits claiming the products increase the risk of necrotizing enterocolitis, which puts newborns at a high risk of permanent injuries and death.

Information About Suboxone Dental Claims To Be Exchanged By Parties in MDL
Information About Suboxone Dental Claims To Be Exchanged By Parties in MDL (Posted 2 days ago)

A federal judge has ordered parties involved in Suboxone dental decay lawsuits to submit proposals for exchanging information that will guide the selection of representative bellwether claims for early test trials.